Aicardi–Goutières syndrome and the type I interferonopathies
The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
Dissection of the genetic basis of Aicardi-Goutières syndrome has highlighted a fundamental link between nucleic acid metabolism, innate immune sensors and type I interferon induction. This had led to the concept of the human interferonopathies as a broader set of Mendelian disorders in which a constitutive upregulation of type I interferon activity directly relates to disease pathology. Here, we discuss the molecular and cellular basis of the interferonopathies, their categorization, future treatment strategies and the insights they provide into normal physiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ADAR edits Alu RNA51, and gain of function mutations in MDA5 suggest that RNA-sensing mechanisms are involved in some AGS cases119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“Aicardi–Goutières syndrome (AGS) is a childhood encephalopathy with similarities to SLE and strong IFN-I induction119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“In fact, hypocomplementia is a common feature of type I interferonopathies66,67”
From Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation (2017) · cites this paper as [66]
In the citing paper
“For example, deficits in RNASEH2, an enzyme responsible for removing ribonucleotides from DNA and resolving R‐loops, comprise more than half of AGS diagnoses (Crow & Manel, 2015).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
In the citing paper
“AGS is caused by mutations in genes that regulate nucleic acid metabolism.”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
Citations
Cites
1 retracted
MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses
Zeng, M., Hu, Z., Shi, X., Li, X., Zhan, X., Li, X.-D., Wang, J., Choi, J. H., Wang, K.-W., Purrington, T., et al. (2014) · Science · doi:10.1126/science.346.6216.1486 · Cited by 112
RetractedMitochondrial DNA stress primes the antiviral innate immune response
West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M., Bestwick, M., Duguay, B. A., Raimundo, N., MacDuff, D. A., et al. (2015) · Nature · doi:10.1038/nature14156 · Cited by 1,975
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Trex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
White, M. J., McArthur, K., Metcalf, D., Lane, R. M., Cambier, J. C., Herold, M. J., van Delft, M. F., Bedoui, S., Lessene, G., Ritchie, M. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.036 · Cited by 983
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Self-citationImmune Interferon in the Circulation of Patients with Autoimmune Disease
Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decker, J. L., & Notkins, A. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907053010102 · Cited by 921
Research works printed but not linked: 1
- Krivine, A., Tovey, M., Taty-Taty, R. & Lebon, P. Endogenous interferon-α in newborns from HIV seropositive mothers. J. Interferon Res. 12, S151 (1992).
Cited by
The cGAS–STING pathway as a therapeutic target in inflammatory diseases
Decout, A., Katz, J. D., Venkatraman, S., & Ablasser, A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00524-z · Cited by 2,309
Molecular mechanisms and cellular functions of cGAS–STING signalling
Hopfner, K.-P., & Hornung, V. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0244-x · Cited by 2,052
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Vanpouille-Box, C., Alard, A., Aryankalayil, M. J., Sarfraz, Y., Diamond, J. M., Schneider, R. J., Inghirami, G., Coleman, C. N., Formenti, S. C., & Demaria, S. (2017) · Nature Communications · doi:10.1038/ncomms15618 · Cited by 1,834
RIG-I-like receptors: their regulation and roles in RNA sensing
Rehwinkel, J., & Gack, M. U. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0288-3 · Cited by 1,699
DNA sensing by the cGAS–STING pathway in health and disease
Motwani, M., Pesiridis, S., & Fitzgerald, K. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0151-1 · Cited by 1,467
Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
Ten things you should know about transposable elements
Bourque, G., Burns, K. H., Gehring, M., Gorbunova, V., Seluanov, A., Hammell, M., Imbeault, M., Izsvák, Z., Levin, H. L., Macfarlan, T. S., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1577-z · Cited by 1,430
Immunogenic cell stress and death
Kroemer, G., Galassi, C., Zitvogel, L., & Galluzzi, L. (2022) · Nature Immunology · doi:10.1038/s41590-022-01132-2 · Cited by 1,353
New insights into the immunopathogenesis of systemic lupus erythematosus
Tsokos, G. C., Lo, M. S., Reis, P. C., & Sullivan, K. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.186 · Cited by 1,226
Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence
Glück, S., Guey, B., Gulen, M. F., Wolter, K., Kang, T.-W., Schmacke, N. A., Bridgeman, A., Rehwinkel, J., Zender, L., & Ablasser, A. (2017) · Nature Cell Biology · doi:10.1038/ncb3586 · Cited by 1,196
“Genetic defects that compromise endogenous DNA metabolism or instances that trigger massive, synchronized accumulation of dead cells represent examples of this phenomenon 26 27 28, 29 30.”
Targeting STING with covalent small-molecule inhibitors
Haag, S. M., Gulen, M. F., Reymond, L., Gibelin, A., Abrami, L., Decout, A., Heymann, M., van der Goot, F. G., Turcatti, G., Behrendt, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0287-8 · Cited by 1,178
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
“Women with dysregulated type I IFN signaling (sustained IFN production or impaired receptor downregulation) exhibit poor pregnancy outcomes including pre-eclampsia as well as neurodevelopmental defects similar to those induced by congenital infection, altogether consistent with a role for dysregulated type I IFN respo…”
Mitochondrial DNA in innate immune responses and inflammatory pathology
West, A. P., & Shadel, G. S. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.21 · Cited by 1,115
cGAS in action: Expanding roles in immunity and inflammation
Ablasser, A., & Chen, Z. J. (2019) · Science · doi:10.1126/science.aat8657 · Cited by 1,077
Mitochondrial DNA in inflammation and immunity
Riley, J. S., & Tait, S. W. (2020) · EMBO reports · doi:10.15252/embr.201949799 · Cited by 865
“In humans, the systemic inflammatory disease Aicardi– Goutières syndrome (AGS) is characterised by mutations in a number of different genes involved in DNA sensing [88].”
R-Loops as Cellular Regulators and Genomic Threats
Crossley, M. P., Bocek, M., & Cimprich, K. A. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.01.024 · Cited by 746
“It is attributed to mutations in nucleic acid-degrading enzymes, including TREX1, SAMHD1 and RNase H2, which cause endogenous nucleic acids to accumulate in the cytoplasm of cells and ultimately activate the cGAS-STING pathway and interferon responses (Crow and Manel, 2015).”
BackgroundMitochondrial double-stranded RNA triggers antiviral signalling in humans
Dhir, A., Dhir, S., Borowski, L. S., Jimenez, L., Teitell, M., Rötig, A., Crow, Y. J., Rice, G. I., Duffy, D., Tamby, C., et al. (2018) · Nature · doi:10.1038/s41586-018-0363-0 · Cited by 631
Self-citationYum, S., Li, M., Fang, Y., & Chen, Z. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100225118 · Cited by 566
“Activation of the immune system by STING is critical for fighting cancer and infectious diseases, but can also lead to autoimmunity (57).”
BackgroundHeterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype
Toubiana, J., Okada, S., Hiller, J., Oleastro, M., Lagos Gomez, M., Aldave Becerra, J. C., Ouachée-Chardin, M., Fouyssac, F., Girisha, K. M., Etzioni, A., et al. (2016) · Blood · doi:10.1182/blood-2015-11-679902 · Cited by 577
Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development
Yockey, L. J., & Iwasaki, A. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.017 · Cited by 559
Recognition of Endogenous Nucleic Acids by the Innate Immune System
Roers, A., Hiller, B., & Hornung, V. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.002 · Cited by 541
Pestal, K., Funk, C. C., Snyder, J. M., Price, N. D., Treuting, P. M., & Stetson, D. B. (2015) · Immunity · doi:10.1016/j.immuni.2015.11.001 · Cited by 513
“I mechanisms that limit activation of intracellular nucleic acid sensors: TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1 (MDA5) (Crow et al., 2015; Crow and Manel, 2015).”
BackgroundPrabakaran, T., Bodda, C., Krapp, C., Zhang, B., Christensen, M. H., Sun, C., Reinert, L., Cai, Y., Jensen, S. B., Skouboe, M. K., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201797858 · Cited by 489
“These mechanisms are important to avoid excess inflammation as evidenced by auto-inflammatory diseases in patient with loss-of-function mutations in genes encoding immune-regulatory proteins (Crow & Manel, 2015).”
The role of retrotransposable elements in ageing and age-associated diseases
Gorbunova, V., Seluanov, A., Mita, P., McKerrow, W., Fenyö, D., Boeke, J. D., Linker, S. B., Gage, F. H., Kreiling, J. A., Petrashen, A. P., et al. (2021) · Nature · doi:10.1038/s41586-021-03542-y · Cited by 446
SAMHD1 acts at stalled replication forks to prevent interferon induction
Coquel, F., Silva, M.-J., Técher, H., Zadorozhny, K., Sharma, S., Nieminuszczy, J., Mettling, C., Dardillac, E., Barthe, A., Schmitz, A.-L., et al. (2018) · Nature · doi:10.1038/s41586-018-0050-1 · Cited by 442
Restricting retrotransposons: a review
Goodier, J. L. (2016) · Mobile DNA · doi:10.1186/s13100-016-0070-z · Cited by 436
“The condition has been associated with mutations in seven genes, including SAMHD1, TREX1, RNASEH2A, RNASEH2B, RNASEH2C, ADAR1, and IFIH1 [492, 493].”
BackgroundRodero, M. P., & Crow, Y. J. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20161596 · Cited by 433
“Likely indicative of intrathecal synthesis, levels of interferon activity in the cerebrospinal fluid of AGS patients are consistently higher than in matched serum samples (Crow et al., 2015).”
BackgroundResultSelf-citationOntogeny and homeostasis of CNS myeloid cells
Prinz, M., Erny, D., & Hagemeyer, N. (2017) · Nature Immunology · doi:10.1038/ni.3703 · Cited by 392
Structure of the Human cGAS–DNA Complex Reveals Enhanced Control of Immune Surveillance
Zhou, W., Whiteley, A. T., de Oliveira Mann, C. C., Morehouse, B. R., Nowak, R. P., Fischer, E. S., Gray, N. S., Mekalanos, J. J., & Kranzusch, P. J. (2018) · Cell · doi:10.1016/j.cell.2018.06.026 · Cited by 387
“However, the enzymatic potential of cGAS necessitates strict regulatory control, and human mutations that disrupt normal tolerance to self-DNA result in severe autoimmunity (Crow and Manel, 2015).”
BackgroundSrikanth, S., Woo, J. S., Wu, B., El-Sherbiny, Y. M., Leung, J., Chupradit, K., Rice, L., Seo, G. J., Calmettes, G., Ramakrishna, C., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0287-8 · Cited by 374
Acetylation Blocks cGAS Activity and Inhibits Self-DNA-Induced Autoimmunity
Dai, J., Huang, Y.-J., He, X., Zhao, M., Wang, X., Liu, Z.-S., Xue, W., Cai, H., Zhan, X.-Y., Huang, S.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.016 · Cited by 371
New frontiers in the cGAS-STING intracellular DNA-sensing pathway
Dvorkin, S., Cambier, S., Volkman, H. E., & Stetson, D. B. (2024) · Immunity · doi:10.1016/j.immuni.2024.02.019 · Cited by 352
Trisomy 21 consistently activates the interferon response
Sullivan, K. D., Lewis, H. C., Hill, A. A., Pandey, A., Jackson, L. P., Cabral, J. M., Smith, K. P., Liggett, L. A., Gomez, E. B., Galbraith, M. D., et al. (2016) · eLife · doi:10.7554/elife.16220 · Cited by 362
“…that IFN activation could contribute to many of the effects of T21, including increased risk of leukemia and autoimmune disorders, as well as many developmental abnormalities also observed in interferonopathies (Yao et al., 2010; Zitvogel et al., 2015; Crow and Manel, 2015; McGlasson et al., 2015).”
BackgroundInfluentialConstitutive immune mechanisms: mediators of host defence and immune regulation
Paludan, S. R., Pradeu, T., Masters, S. L., & Mogensen, T. H. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-0391-5 · Cited by 362
Regulation of cGAS- and RLR-mediated immunity to nucleic acids
Ablasser, A., & Hur, S. (2020) · Nature Immunology · doi:10.1038/s41590-019-0556-1 · Cited by 337
Thomas, C. A., Tejwani, L., Trujillo, C. A., Negraes, P. D., Herai, R. H., Mesci, P., Macia, A., Crow, Y. J., & Muotri, A. R. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.07.009 · Cited by 330
Self-citationTam, O. H., Rozhkov, N. V., Shaw, R., Kim, D., Hubbard, I., Fennessey, S., Propp, N., Phatnani, H., Kwan, J., Sareen, D., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.066 · Cited by 327
“Additional studies have shown that expressed retrotransposon RNAs can also be toxic through aberrant recognition by innate immune components in Aicardi-Goutières syndrome (Crow and Manel, 2015).”
Majoros, A., Platanitis, E., Kernbauer-Hölzl, E., Rosebrock, F., Müller, M., & Decker, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00029 · Cited by 325
“On the other hand, their proinflammatory activity renders them driving forces behind a group of interferonopathies, such as the AicardiGoutieres syndrome (12, 13).”
BackgroundA Balancing Act: MDA5 in Antiviral Immunity and Autoinflammation
Dias Junior, A. G., Sampaio, N. G., & Rehwinkel, J. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.08.007 · Cited by 317
“Further evidence for the role of MDA5 and MAVS in inducing type I IFN downstream of ADAR1deficiency was obtained in animals expressing an editing-deficient version of ADAR1 (E861A) [86].”
BackgroundInfluentialDNA Damage and Cancer Immunotherapy: A STING in the Tale
Reisländer, T., Groelly, F. J., & Tarsounas, M. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.07.026 · Cited by 314
Mitochondria, Oxidative Stress and Innate Immunity
Chen, Y., Zhou, Z., & Min, W. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01487 · Cited by 315
“…infection, it is also essential to orchestrate type I interferon (IFN) and proinflammatory responses to self-DNA, driving type I IFN induction and ultimately resulting in autoimmune responses as well as antitumor immunity (Barber, 2015; Crow and Manel, 2015; Gray et al., 2015; Roers et al., 2016).”
BackgroundNew insights into the role of antinuclear antibodies in systemic lupus erythematosus
Pisetsky, D. S., & Lipsky, P. E. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0480-7 · Cited by 303
Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes
Cerboni, S., Jeremiah, N., Gentili, M., Gehrmann, U., Conrad, C., Stolzenberg, M.-C., Picard, C., Neven, B., Fischer, A., Amigorena, S., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161674 · Cited by 299
“Genetic defects in components of the innate nucleic acid–sensing and –signaling pathway leading to an increase in the production of type I IFNs have been identified and grouped as interferonopathies (Crow and Manel, 2015).”
BackgroundSelf-citationG3BP1 promotes DNA binding and activation of cGAS
Liu, Z.-S., Cai, H., Xue, W., Wang, M., Xia, T., Li, W.-J., Xing, J.-Q., Zhao, M., Huang, Y.-J., Chen, S., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0262-4 · Cited by 290
STING inhibitors target the cyclic dinucleotide binding pocket
Hong, Z., Mei, J., Li, C., Bai, G., Maimaiti, M., Hu, H., Yu, W., Sun, L., Zhang, L., Cheng, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105465118 · Cited by 273
“Flag-STING(138-379) Flag-STING(1-341) Flag-STING(del138-340) Flag-STING Flag-STING(138-379) Flag-STING(1-341)”
Lee, H., Fenster, R. J., Pineda, S. S., Gibbs, W. S., Mohammadi, S., Davila-Velderrain, J., Garcia, F. J., Therrien, M., Novis, H. S., Gao, F., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.021 · Cited by 279
“…basal ganglia (Alfadhel et al., 2013; Kornreich et al., 2005), as has been Aicardi-Goutie`res syndrome, an autoinflammatory disorder that displays inappropriate activation of innate immune signaling and constitutive upregulation of type I interferon (IFN) - induced signaling (Crow and Manel, 2015).”
BackgroundResearch Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response
Wan, D., Jiang, W., & Hao, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00615 · Cited by 270
“AGS comprises some systemic autoimmune syndromes overlapping with SLE, and can be classified as a "lupuslike disease" (173) .”
BackgroundDeczkowska, A., Matcovitch-Natan, O., Tsitsou-Kampeli, A., Ben-Hamo, S., Dvir-Szternfeld, R., Spinrad, A., Singer, O., David, E., Winter, D. R., Smith, L. K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00769-0 · Cited by 260
Gasdermin D Restrains Type I Interferon Response to Cytosolic DNA by Disrupting Ionic Homeostasis
Banerjee, I., Behl, B., Mendonca, M., Shrivastava, G., Russo, A. J., Menoret, A., Ghosh, A., Vella, A. T., Vanaja, S. K., Sarkar, S. N., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.006 · Cited by 261
“Type I interferons are pleiotropic cytokines associated with immunopathology and autoimmunity when produced in excess, thus necessitating a critical need for the host to keep the cGAS pathway in check (Crow and Manel, 2015).”
Ribonuclease H2 mutations induce a cGAS/STING‐dependent innate immune response
Mackenzie, K. J., Carroll, P., Lettice, L., Tarnauskaitė, Ž., Reddy, K., Dix, F., Revuelta, A., Abbondati, E., Rigby, R. E., Rabe, B., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593339 · Cited by 248
“Intracellular accumulation of aberrant nucleic acid species is believed to trigger intrinsic nucleic acid sensors initiating auto-immunity in AGS (Crow & Manel, 2015).”
InfluentialRewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs
Walkley, C. R., & Li, J. B. (2017) · Genome Biology · doi:10.1186/s13059-017-1347-3 · Cited by 235
“Crow YJ, Chase DS, Lowenstein Schmidt J, Szynkiewicz M, Forte GM, Gornall HL, et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.”
BackgroundFrémond, M.-L., Rodero, M. P., Jeremiah, N., Belot, A., Jeziorski, E., Duffy, D., Bessis, D., Cros, G., Rice, G. I., Charbit, B., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.015 · Cited by 235
Self-citationTrisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation
Sullivan, K. D., Evans, D., Pandey, A., Hraha, T. H., Smith, K. P., Markham, N., Rachubinski, A. L., Wolter-Warmerdam, K., Hickey, F., Espinosa, J. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13858-3 · Cited by 228
Erdal, E., Haider, S., Rehwinkel, J., Harris, A. L., & McHugh, P. J. (2017) · Genes & Development · doi:10.1101/gad.289769.116 · Cited by 227
“Moreover, RNase H2 deficiency, the most frequent cause of the autoinflammatory disease Aicardi-Goutières syndrome (AGS), triggers cGAS/STING activation (Crow and Manel 2015; Mackenzie et al. 2016; Pokatayev et al. 2016).”
BackgroundCD8+ T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging
Kaya, T., Mattugini, N., Liu, L., Ji, H., Cantuti-Castelvetri, L., Wu, J., Schifferer, M., Groh, J., Martini, R., Besson-Girard, S., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01183-6 · Cited by 224
Intracellular Nucleic Acid Detection in Autoimmunity
Crowl, J. T., Gray, E. E., Pestal, K., Volkman, H. E., & Stetson, D. B. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052331 · Cited by 223
“AGS patients develop abundant autoantibodies that only partially overlap with those found in SLE (51, 139).”
BackgroundInfluentialCellular Stress Associated with Aneuploidy
Zhu, J., Tsai, H.-J., Gordon, M. R., & Li, R. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.02.002 · Cited by 222
Gene expression variability across cells and species shapes innate immunity
Hagai, T., Chen, X., Miragaia, R. J., Rostom, R., Gomes, T., Kunowska, N., Henriksson, J., Park, J.-E., Proserpio, V., Donati, G., et al. (2018) · Nature · doi:10.1038/s41586-018-0657-2 · Cited by 220
Transcriptional Regulation of Antiviral Interferon-Stimulated Genes
Wang, W., Xu, L., Su, J., Peppelenbosch, M. P., & Pan, Q. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.01.001 · Cited by 219
“In preclinical or clinical studies, the expression patterns of some specific ISGs have been identified as biomarkers to predict treatment responses, disease progression, or outcomes in both infectious (e.g., HCV and HIV infections) [121] [122] [123] and non-infectious human diseases (e.g., Aicardi-Goutières syndrome a…”
BackgroundExome and genome sequencing for inborn errors of immunity
Meyts, I., Bosch, B., Bolze, A., Boisson, B., Itan, Y., Belkadi, A., Pedergnana, V., Moens, L., Picard, C., Cobat, A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.003 · Cited by 215
“Likewise ISG15, an anti-IFN-γ -inducing molecule was shown to be a strong negative regulator of IFN-α / β immunity through USP18 (78–80).”
Mayer-Barber, K. D., & Yan, B. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.25 · Cited by 213
Zhang, Z., Zhou, H., Ouyang, X., Dong, Y., Sarapultsev, A., Luo, S., & Hu, D. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01252-z · Cited by 208
“Disturbed self-DNA metabolism caused by a mutation in the TREX1 gene and genes encoding the three RNase H2 endonuclease subunits, RNASEH2A, RNASEH2C, and SAMHD1 is the etiology of another rare genetic disorder, Aicardi–Goutières syndrome.(162) Similarly, hypomorphic mutations in DNASE2 are related to a clinical syndro…”
BackgroundLee-Kirsch, M. A. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-104506 · Cited by 210
Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
Rice, G. I., Melki, I., Frémond, M.-L., Briggs, T. A., Rodero, M. P., Kitabayashi, N., Oojageer, A., Bader-Meunier, B., Belot, A., Bodemer, C., et al. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0359-1 · Cited by 209
Self-citationER-directed TREX1 limits cGAS activation at micronuclei
Mohr, L., Toufektchan, E., von Morgen, P., Chu, K., Kapoor, A., & Maciejowski, J. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.12.037 · Cited by 204
“Finally, frameshift mutations that eliminate TREX1’s C-terminal extension are associated with systemic lupus erythematosus (SLE) and retinal vasculopathy with cerebral leukodystrophy (RVCL) (Lee-Kirsch et al., 2007; Richards et al., 2007).”
BackgroundInfluentialSTING-associated vasculopathy develops independently of IRF3 in mice
Warner, J. D., Irizarry-Caro, R. A., Bennion, B. G., Ai, T. L., Smith, A. M., Miner, C. A., Sakai, T., Gonugunta, V. K., Wu, J., Platt, D. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171351 · Cited by 206
“, 2017), as occurs in other interferonopathies (Crow and Manel, 2015; Kim et al., 2016), but this had not previously been tested experimentally in an animal model with a human disease-causing STI NG mutation.”
BackgroundAbsence of RNase H2 triggers generation of immunogenic micronuclei removed by autophagy
Bartsch, K., Knittler, K., Borowski, C., Rudnik, S., Damme, M., Aden, K., Spehlmann, M. E., Frey, N., Saftig, P., Chalaris, A., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx283 · Cited by 196
TLR8 Is a Sensor of RNase T2 Degradation Products
Greulich, W., Wagner, M., Gaidt, M. M., Stafford, C., Cheng, Y., Linder, A., Carell, T., & Hornung, V. (2019) · Cell · doi:10.1016/j.cell.2019.11.001 · Cited by 197
Mitochondrial dysfunction as a trigger of innate immune responses and inflammation
West, A. P. (2017) · Toxicology · doi:10.1016/j.tox.2017.07.016 · Cited by 200
cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing
Uggenti, C., Lepelley, A., Depp, M., Badrock, A. P., Rodero, M. P., El-Daher, M.-T., Rice, G. I., Dhir, S., Wheeler, A. P., Dhir, A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00737-3 · Cited by 192
Self-citationCellular Innate Immunity: An Old Game with New Players
Gasteiger, G., D'Osualdo, A., Schubert, D. A., Weber, A., Bruscia, E. M., & Hartl, D. (2017) · Journal of Innate Immunity · doi:10.1159/000453397 · Cited by 190
Mavragani, C. P., Sagalovskiy, I., Guo, Q., Nezos, A., Kapsogeorgou, E. K., Lu, P., Liang Zhou, J., Kirou, K. A., Seshan, S. V., Moutsopoulos, H. M., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39795 · Cited by 187
Teissier, T., & Boulanger, É. (2019) · Biogerontology · doi:10.1007/s10522-019-09808-3 · Cited by 179
“With the accumulation of PAMPs and DAMPs with age, such as cytoplasmic or cell-free DNA (Crow and Manel 2015; Dou et al. 2017; Mankan et al. 2014; Shen et al. 2015; Shimada et al. 2012), a ‘‘Garb-aging’’ theory has been proposed where excess production or a lack of clearance of molecular…”
BackgroundTeruel, M., & Alarcón-Riquelme, M. E. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.08.001 · Cited by 177
Hall, J., Brault, A., Vincent, F., Weng, S., Wang, H., Dumlao, D., Aulabaugh, A., Aivazian, D., Castro, D., Chen, M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184843 · Cited by 167
“From a chemical optimization perspective this was not attractive and thus several chemically stable [6,5] ring systems were synthesized in an attempt to find a core that would recapitulate the active pharmacophore and not isomerize.”
BackgroundToward Precision Radiotherapy for Use with Immune Checkpoint Blockers
Vanpouille-Box, C., Formenti, S. C., & Demaria, S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0037 · Cited by 171
“Accordingly, Trex1 / mice develop an IFN-I–driven autoimmune disorder, and mutation in TREX1 in humans is associated with Aicardi–Gouti eres syndrome, an early-onset inflammatory disorder affecting multiple organs (48, 49).”
Okada, S., Asano, T., Moriya, K., Boisson-Dupuis, S., Kobayashi, M., Casanova, J.-L., & Puel, A. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00847-x · Cited by 171
Type I interferon–mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy
Psarras, A., Emery, P., & Vital, E. M. (2017) · Rheumatology · doi:10.1093/rheumatology/kew431 · Cited by 168
Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1
Colomer-Lluch, M., Ruiz, A., Moris, A., & Prado, J. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02876 · Cited by 167
“In fact, deficiency in SAMHD1 leads to increased IFN production, upon viral DNA sensing by cGAS, and innate immune activation causing autoimmune disorders in patients (74).”
BackgroundVulnerability of primitive human placental trophoblast to Zika virus
Sheridan, M. A., Yunusov, D., Balaraman, V., Alexenko, A. P., Yabe, S., Verjovski-Almeida, S., Schust, D. J., Franz, A. W., Sadovsky, Y., Ezashi, T., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616097114 · Cited by 166
“3), except under certain pathological conditions (54).”
Interferon-induced guanylate-binding proteins in inflammasome activation and host defense
Kim, B.-H., Chee, J. D., Bradfield, C. J., Park, E.-S., Kumar, P., & MacMicking, J. D. (2016) · Nature Immunology · doi:10.1038/ni.3440 · Cited by 160
Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy
Wu, J., Zhao, L., Hu, H., Li, W., & Li, Y. (2020) · Medicinal Research Reviews · doi:10.1002/med.21649 · Cited by 157
Innate Immune Response to Cytoplasmic DNA: Mechanisms and Diseases
Hu, M., & Shu, H. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-070119-115052 · Cited by 167
Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach
Nigrovic, P. A., Lee, P. Y., & Hoffman, H. M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.017 · Cited by 174
Genome integrity and disease prevention in the nervous system
McKinnon, P. J. (2017) · Genes & Development · doi:10.1101/gad.301325.117 · Cited by 157
“…includingmicrocephaly (clinically defined as a head circumference three or more standard deviations below the mean for age and gender), and is considered to arise because of failed nucleic acid clearance, resulting in an interferon response leading to severe neuroinflammation (Crow and Manel 2015).”
BackgroundGenetic and epigenetic defects of the RNA modification machinery in cancer
Oršolić, I., Carrier, A., & Esteller, M. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.10.004 · Cited by 162
Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome
Rice, G. I., Meyzer, C., Bouazza, N., Hully, M., Boddaert, N., Semeraro, M., Zeef, L. A. H., Rozenberg, F., Bondet, V., Duffy, D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1810983 · Cited by 153
Self-citationDNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesis
Starokadomskyy, P., Gemelli, T., Rios, J. J., Xing, C., Wang, R. C., Li, H., Pokatayev, V., Dozmorov, I., Khan, S., Miyata, N., et al. (2016) · Nature Immunology · doi:10.1038/ni.3409 · Cited by 152
“The most prominent condition in this category is Aicardi-Goutières syndrome (AGS), a rare genetic disorder affecting the brain, skin and other organs 4–6 .”
Feng, X., Tubbs, A., Zhang, C., Tang, M., Sridharan, S., Wang, C., Jiang, D., Su, D., Zhang, H., Chen, Z., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104036 · Cited by 145
“Aberrant activation of MDA5 could cause autoimmune and autoinflammatory diseases such as systemic lupus erythematosus and Aicardi – Goutie`res syndrome (Crow & Manel, 2015; Barrat et al , 2016).”
Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models
Motwani, M., Pawaria, S., Bernier, J., Moses, S., Henry, K., Fang, T., Burkly, L., Marshak-Rothstein, A., & Fitzgerald, K. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818281116 · Cited by 143
“Discussion A variety of mutations in genes associated with the metabolism or sensing of endogenous nucleic acids lead to an assortment of clinical syndromes that are collectively referred to as “type I interferonopathies,” because these patients share an elevated IFN gene signature (3, 26).”
BackgroundThe role of RNA editing enzyme ADAR1 in human disease
Song, B., Shiromoto, Y., Minakuchi, M., & Nishikura, K. (2022) · WIREs RNA · doi:10.1002/wrna.1665 · Cited by 142
“There are currently seven genes (TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, IFIH1) confirmed to be associated with AGS, and mutations in any of them can cause the syndrome (Crow & Manel, 2015).”
BackgroundSelf-Awareness: Nucleic Acid–Driven Inflammation and the Type I Interferonopathies
Uggenti, C., Lepelley, A., & Crow, Y. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041257 · Cited by 137
Self-citationBrain Organoids and the Study of Neurodevelopment
Trujillo, C. A., & Muotri, A. R. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.09.005 · Cited by 149
Kim, H., Brooks, K. M., Tang, C. C., Wakim, P., Blake, M., Brooks, S. R., Sanchez, G. A. M., de Jesus, A. A., Huang, Y., Tsai, W. L., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.936 · Cited by 139
“A US Food and Drug Administration (FDA)-approved compassionate use program (NCT01724580) was initiated in 2011 for the treatment of pediatric patients with rare Mendelian autoinflammatory diseases (AIDs) with presumed interferon (IFN)-mediated pathology.(1,2) Patients with chronic atypical neutrophilic dermatosis with…”
BackgroundA new horizon of moyamoya disease and associated health risks explored through RNF213
Koizumi, A., Kobayashi, H., Hitomi, T., Harada, K. H., Habu, T., & Youssefian, S. (2015) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-015-0498-7 · Cited by 139
“[88] Inflammation Inflammation activated thrombosis Sneddon’s syndrome [66–69] CECR1 [124] Excessive Type I interferon production Aicardi–Goutieres syndrome [65] SAMHD1 [65] TRX1 ACP5 Vascular smooth muscle cell dysfunction eNOS production Moyamoya and achalasia syndrome [71] GUCY1A3 ibid.”
BackgroundGkirtzimanaki, K., Kabrani, E., Nikoleri, D., Polyzos, A., Blanas, A., Sidiropoulos, P., Makrigiannakis, A., Bertsias, G., Boumpas, D. T., & Verginis, P. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.001 · Cited by 133
ADAR RNA editing in human disease; more to it than meets the I
Gallo, A., Vukić, D., Michalík, D., O’Connell, M. A., & Keegan, L. P. (2017) · Human Genetics · doi:10.1007/s00439-017-1837-0 · Cited by 138
The cGAS‐STING pathway: The role of self‐DNA sensing in inflammatory lung disease
Ma, R., Serrano, T. P. O., Davis, J., Prigge, A. D., & Ridge, K. M. (2020) · The FASEB Journal · doi:10.1096/fj.202001607r · Cited by 151
Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease
Welch, G., & Tsai, L. (2022) · The EMBO Reports · doi:10.15252/embr.202154217 · Cited by 129
“For example, deficits in RNASEH2, an enzyme responsible for removing ribonucleotides from DNA and resolving R-loops, comprise more than half of AGS diagnoses (Crow & Manel, 2015).”
Type I/II Interferon Balance in the Regulation of Brain Physiology and Pathology
Deczkowska, A., Baruch, K., & Schwartz, M. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.006 · Cited by 143
Metadata
- Authors
- Crow, Y. J., & Manel, N.
- Affiliations
- Inserm (FR)
- Corresponding author
- Crow, Yanick J.
- Venue
- Nature Reviews Immunology
- Published
- 2015-06-05
- Volume
- 15
- Issue
- 7
- Pages
- 429-440
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1542158376
- Cited by
- 925
- References
- 106
- Citations by year
- 2026: 63 · 2025: 80 · 2024: 83 · 2023: 92 · 2022: 103 · 2021: 92 · 2020: 82 · 2019: 80 · 2018: 71 · 2017: 88 · 2016: 75 · 2015: 16
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-IDEX-0001, ANR-11-LABX-0043)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- Aicardi-Goutières syndrome, type I interferonopathy, type I interferon, innate immune signaling, monogenic disorders, nucleic acid metabolism, innate immune sensors, interferon induction, interferonopathies, treatment options
- MeSH terms
- Animals, Humans, Interferon Type I, Nervous System Malformations, Autoimmune Diseases of the Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.